EP Patent

EP1559418A1 — Compositions for treating pain of the mucous membrane

Assigned to Immune Pharmaceuticals Inc · Expires 2005-08-03 · 21y expired

What this patent protects

Compositions useful for long-lasting pain relief from mucosal damage, such as mucosal inflammation, abrasions, ulcerations, lesions, trauma and incisions, without significant systemic absorption. The compositions of the invention are particularly suitable for application to the m…

USPTO Abstract

Compositions useful for long-lasting pain relief from mucosal damage, such as mucosal inflammation, abrasions, ulcerations, lesions, trauma and incisions, without significant systemic absorption. The compositions of the invention are particularly suitable for application to the mucous membrane of the nasal cavity and bucal cavity. To relieve pain, the compositions or the invention are topically applied directly to the affected area.

Drugs covered by this patent

Patent Metadata

Patent number
EP1559418A1
Jurisdiction
EP
Classification
Expires
2005-08-03
Drug substance claim
No
Drug product claim
No
Assignee
Immune Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.